Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Immunotherapy|November 9, 2018
Factors associated with immunotherapy selection in patients with advanced melanomaRichard W Joseph, Alicia C Shillington, Cynthia Macahilig, et al.
Gynecologic Oncology|November 7, 2022
Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United StatesSneha S Kelkar, Vimalanand S Prabhu, Shelby Corman, et al.
Clinical Genitourinary Cancer|September 10, 2022
Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor TherapyAlicia K Morgans, Simrun Grewal, Zsolt Hepp, et al.
Gynecologic Oncology Reports|July 8, 2022
Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United StatesSneha S Kelkar, Vimalanand S Prabhu, Jingchuan Zhang, et al.
International Journal of Hematology|January 15, 2015
Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostimDavid J Kuter, Cynthia Macahilig, Kelly M Grotzinger, et al.
Leukemia & Lymphoma|October 19, 2017
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and GermanyErin A Zagadailov, Shelby Corman, Viktor Chirikov, et al.
Infection and Drug Resistance|July 1, 2015
Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab EmiratesAshraf El Houfi, Nadeem Javed, Caitlyn T Solem, et al.
European Journal of Haematology|September 27, 2017
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective studyPaul J Bröckelmann, Erin A Zagadailov, Shelby L Corman, et al.
BMC Infectious Diseases|September 4, 2014
Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in EuropeDilip Nathwani, Christian Eckmann, Wendy Lawson, et al.
Journal of Infection and Public Health|June 3, 2020
Early switch/early discharge opportunities for hospitalized patients with methicillin resistant Staphylococcus aureus complicated skin and soft tissue infections: Saudi Arabia and United Arab EmiratesAshraf El Houfi, Abdulhakeem Al Thaqafi, Thamer H Alenazi, et al.
Pageof 3